Brian Abrahams
Stock Analyst at RBC Capital
(4.76)
# 631
Out of 4,974 analysts
1809
Total ratings
54.1%
Success rate
13.1%
Average return
Main Sectors:
Stocks Rated by Brian Abrahams
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AARD Aardvark Therapeutics | Reiterated: Hold | $6 | $5.02 | +19.52% | 10 | Sep 14, 2026 | |
| NBIX Neurocrine Biosciences | Reiterated: Buy | $198 | $150.02 | +31.98% | 95 | Sep 14, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $66 | $36.82 | +79.25% | 23 | Sep 11, 2026 | |
| BCRX BioCryst Pharmaceuticals | Downgraded: Hold | $13 → $11 | $8.16 | +34.80% | 101 | Sep 10, 2026 | |
| REGN Regeneron Pharmaceuticals | Reiterated: Hold | $737 | $774.11 | -4.79% | 84 | Sep 10, 2026 | |
| GILD Gilead Sciences | Reiterated: Hold | $123 | $146.30 | -15.93% | 214 | Sep 9, 2026 | |
| EVMN Evommune | Reiterated: Buy | $29 → $21 | $9.99 | +110.21% | 7 | Sep 8, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $23 | $13.82 | +66.43% | 15 | Sep 3, 2026 | |
| ATTO Attovia Therapeutics | Reiterated: Buy | $45 | $23.70 | +89.87% | 2 | Sep 2, 2026 | |
| KYMR Kymera Therapeutics | Reiterated: Hold | $112 | $113.15 | -1.02% | 9 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $240 → $260 | $216.17 | +20.28% | 201 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.8313 | +501.47% | 22 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.54 | +419.48% | 109 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $6.92 | +420.23% | 33 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $570 | $514.63 | +10.76% | 152 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 | $1.12 | +78.57% | 31 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $24.75 | +61.62% | 4 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $26 | $27.90 | -6.81% | 59 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $12.20 | +39.34% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $36 | $24.83 | +44.99% | 11 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $23 → $5 | $6.88 | -27.33% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $0.3892 | +156.94% | 7 | Aug 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $42 | $27.55 | +52.45% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $8.33 | +56.06% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $81 | $56.28 | +43.92% | 34 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $19 | $20.72 | -8.30% | 136 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $37 | $26.76 | +38.27% | 15 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $85 | $65.65 | +29.47% | 102 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $99 → $109 | $121.74 | -10.46% | 137 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $128 | $93.90 | +36.32% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39.00 | $49.52 | -21.24% | 1 | Oct 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $15 | $12.29 | n/a | 54 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $288 | $12.89 | n/a | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $2.71 | n/a | 15 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $188 | $375.65 | n/a | 6 | Oct 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $5.47 | n/a | 1 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $217.77 | n/a | 1 | May 17, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $13.07 | n/a | 2 | May 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $143.17 | n/a | 1 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.75 | $15.84 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 | $45.33 | n/a | 1 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $47 → $47 | $70.42 | n/a | 2 | Mar 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $43.10 | n/a | 1 | Mar 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 11 | Feb 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $11.76 | n/a | 3 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $106.20 | n/a | 1 | Jan 5, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $38.51 | n/a | 2 | Nov 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $24.42 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $41.90 | n/a | 1 | Nov 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $122 | $94.49 | n/a | 3 | Nov 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $64.45 | n/a | 4 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $263.04 | n/a | 4 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $39.25 | n/a | 1 | Aug 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $63.73 | n/a | 4 | Aug 22, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.16 | n/a | 5 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,136.11 | n/a | 2 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $267.20 | n/a | 2 | Aug 1, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $1.61 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $143.79 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $27.55 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $138.62 | n/a | 1 | Apr 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $44.36 | n/a | 2 | Feb 23, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.66 | n/a | 1 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.23 | n/a | 1 | Sep 2, 2009 |
Aardvark Therapeutics
Sep 14, 2026
Reiterated: Hold
Price Target: $6
Current: $5.02
Upside: +19.52%
Neurocrine Biosciences
Sep 14, 2026
Reiterated: Buy
Price Target: $198
Current: $150.02
Upside: +31.98%
Definium Therapeutics
Sep 11, 2026
Reiterated: Buy
Price Target: $66
Current: $36.82
Upside: +79.25%
BioCryst Pharmaceuticals
Sep 10, 2026
Downgraded: Hold
Price Target: $13 → $11
Current: $8.16
Upside: +34.80%
Regeneron Pharmaceuticals
Sep 10, 2026
Reiterated: Hold
Price Target: $737
Current: $774.11
Upside: -4.79%
Gilead Sciences
Sep 9, 2026
Reiterated: Hold
Price Target: $123
Current: $146.30
Upside: -15.93%
Evommune
Sep 8, 2026
Reiterated: Buy
Price Target: $29 → $21
Current: $9.99
Upside: +110.21%
Contineum Therapeutics
Sep 3, 2026
Reiterated: Buy
Price Target: $23
Current: $13.82
Upside: +66.43%
Attovia Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $45
Current: $23.70
Upside: +89.87%
Kymera Therapeutics
Sep 2, 2026
Reiterated: Hold
Price Target: $112
Current: $113.15
Upside: -1.02%
Aug 25, 2026
Rated: Buy
Price Target: $240 → $260
Current: $216.17
Upside: +20.28%
Aug 14, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8313
Upside: +501.47%
Aug 13, 2026
Reiterated: Buy
Price Target: $8
Current: $1.54
Upside: +419.48%
Aug 12, 2026
Reiterated: Buy
Price Target: $36
Current: $6.92
Upside: +420.23%
Aug 12, 2026
Reiterated: Buy
Price Target: $570
Current: $514.63
Upside: +10.76%
Aug 11, 2026
Reiterated: Hold
Price Target: $2
Current: $1.12
Upside: +78.57%
Aug 10, 2026
Reiterated: Buy
Price Target: $40
Current: $24.75
Upside: +61.62%
Aug 10, 2026
Rated: Hold
Price Target: $28 → $26
Current: $27.90
Upside: -6.81%
Aug 10, 2026
Reiterated: Hold
Price Target: $16 → $17
Current: $12.20
Upside: +39.34%
Aug 10, 2026
Reiterated: Buy
Price Target: $33 → $36
Current: $24.83
Upside: +44.99%
Aug 10, 2026
Upgraded: Hold
Price Target: $23 → $5
Current: $6.88
Upside: -27.33%
Aug 9, 2026
Reiterated: Hold
Price Target: $1
Current: $0.3892
Upside: +156.94%
Aug 6, 2026
Reiterated: Buy
Price Target: $40 → $42
Current: $27.55
Upside: +52.45%
Aug 6, 2026
Reiterated: Hold
Price Target: $13
Current: $8.33
Upside: +56.06%
Aug 6, 2026
Reiterated: Buy
Price Target: $82 → $81
Current: $56.28
Upside: +43.92%
Aug 5, 2026
Reiterated: Hold
Price Target: $19
Current: $20.72
Upside: -8.30%
Aug 4, 2026
Rated: Buy
Price Target: $36 → $37
Current: $26.76
Upside: +38.27%
Jul 30, 2026
Reiterated: Hold
Price Target: $85
Current: $65.65
Upside: +29.47%
Jul 28, 2026
Reiterated: Hold
Price Target: $99 → $109
Current: $121.74
Upside: -10.46%
Apr 7, 2026
Reiterated: Buy
Price Target: $128
Current: $93.90
Upside: +36.32%
Oct 26, 2025
Reiterated: Buy
Price Target: $39.00
Current: $49.52
Upside: -21.24%
Oct 2, 2023
Reiterated: Hold
Price Target: $25 → $15
Current: $12.29
Upside: n/a
Oct 28, 2022
Reiterated: Hold
Price Target: $288
Current: $12.89
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: $4
Current: $2.71
Upside: n/a
Oct 26, 2017
Reiterated: Hold
Price Target: $188
Current: $375.65
Upside: n/a
Sep 15, 2017
Initiated Coverage: Buy
Price Target: $23
Current: $5.47
Upside: n/a
May 17, 2017
Reiterated: Buy
Price Target: $135
Current: $217.77
Upside: n/a
May 8, 2017
Reiterated: Hold
Price Target: $68
Current: $13.07
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $80
Current: $143.17
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $8.75
Current: $15.84
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $32
Current: $45.33
Upside: n/a
Mar 31, 2017
Reiterated: Hold
Price Target: $47 → $47
Current: $70.42
Upside: n/a
Mar 7, 2017
Reiterated: Hold
Price Target: $8
Current: $43.10
Upside: n/a
Feb 16, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $47
Current: $11.76
Upside: n/a
Jan 5, 2017
Reiterated: Buy
Price Target: $42
Current: $106.20
Upside: n/a
Nov 23, 2016
Reiterated: Hold
Price Target: $4 → $5
Current: $38.51
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $39
Current: $24.42
Upside: n/a
Nov 16, 2016
Reiterated: Buy
Price Target: $46
Current: $41.90
Upside: n/a
Nov 1, 2016
Reiterated: Buy
Price Target: $122
Current: $94.49
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $120
Current: $64.45
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $263.04
Upside: n/a
Aug 25, 2016
Reiterated: Buy
Price Target: n/a
Current: $39.25
Upside: n/a
Aug 22, 2016
Reiterated: Hold
Price Target: n/a
Current: $63.73
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $7.16
Upside: n/a
Aug 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $1,136.11
Upside: n/a
Aug 1, 2016
Reiterated: Hold
Price Target: n/a
Current: $267.20
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $1.61
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: n/a
Current: $143.79
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: n/a
Current: $27.55
Upside: n/a
Apr 21, 2016
Reiterated: Buy
Price Target: $61
Current: $138.62
Upside: n/a
Feb 23, 2015
Reiterated: Hold
Price Target: n/a
Current: $44.36
Upside: n/a
Jun 25, 2012
Downgraded: Hold
Price Target: n/a
Current: $2.66
Upside: n/a
Sep 2, 2009
Downgraded: Hold
Price Target: n/a
Current: $9.23
Upside: n/a